Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 2Withdrawn 1Unknown 1

Sponsor Class

OTHER 4INDUSTRY 3

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gynecologic 2Thoracic 1Gastrointestinal 1

Conditions

Endometrial Neoplasms 2Lung Neoplasms 1Colonic Neoplasms 1

Interventions

Cyclophosphamide 2067Radiotherapy 1990Cisplatin 1856Carboplatin 1560Gemcitabine 1454Paclitaxel 1320Bevacizumab 1320pembrolizumab 1238Docetaxel 1227Oxaliplatin 1184Capecitabine 1178Fluorouracil 1083Dexamethasone 979Magnetic Resonance Spectroscopy 971Nivolumab 936Rituximab 929Drug Therapy 915Surveys and Questionnaires 899Doxorubicin 845Etoposide 843Radiosurgery 816Blood Specimen Collection 816Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 640Lenalidomide 618Biopsy 594fludarabine phosphate 569

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Appointments and Schedules × Clear all
NCT06628167 2026-03-24

LCS II

Abramson Cancer Center at Penn Medicine

Phase NA Completed
252 enrolled 7 charts
Thoracic

Lung Neoplasms

NCT04274790 2024-02-14

FLUORIB

Centre Leon Berard

Withdrawn
Gastrointestinal

Colonic Neoplasms

NCT04763902 2023-11-30

TIMESPAN

University of Utah

Phase NA Completed
17 enrolled
Gynecologic

Endometrial Neoplasms

NCT04783467 2023-11-30

TREND

University of Utah

Phase NA Unknown
15 enrolled
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡